Asthma
Not recruitingStudy on Tezepelumab for Patients with Severe Asthma
- Disease:Asthma
- Substances:Tezepelumab
France- Participants:18–64 years · 65+ years
- Substances:Tezepelumab
- Sponsor:Centre Hospitalier Universitaire De Montpellier
Rare diseases
Investigational molecules
Locations
Back to France296 clinical trials in Le Kremlin-Bicetre, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)
France
France
France
France
France
France
France
France
France
France
France
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative studies exploring treatments for inflammatory bowel diseases, with multiple trials investigating fecal microbiota transplantation as a therapeutic approach for Crohn's disease and ulcerative colitis. Research focuses on maintaining remission and improving patient outcomes.
Clinical research targeting neurological conditions, including trials for Myasthenia Gravis and innovative treatments for aneurysmal subarachnoid hemorrhage. Studies aim to improve daily living activities and patient outcomes.
Comprehensive research into autoimmune conditions, including studies on rheumatoid arthritis and Sjögren's syndrome. Trials evaluate novel therapeutic approaches and maintenance treatments for improved disease management.
Advanced research in respiratory conditions, including studies on pulmonary hypertension, severe asthma, and interstitial lung disease. Trials focus on evaluating new treatments and improving patient care strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.